DexCom Retained Earnings (Accumulated Deficit) 2010-2025 | DXCM

DexCom retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • DexCom retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $1.703B, a 45.83% increase year-over-year.
  • DexCom retained earnings (accumulated deficit) for 2024 were $1.598B, a 56.41% increase from 2023.
  • DexCom retained earnings (accumulated deficit) for 2023 were $1.021B, a 112.84% increase from 2022.
  • DexCom retained earnings (accumulated deficit) for 2022 were $0.48B, a 246% increase from 2021.
DexCom Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $1,598
2023 $1,021
2022 $480
2021 $139
2020 $-202
2019 $-696
2018 $-799
2017 $-672
2016 $-621
2015 $-555
2014 $-498
2013 $-475
2012 $-446
2011 $-391
2010 $-346
2009 $-291
DexCom Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2025-03-31 $1,703
2024-12-31 $1,598
2024-09-30 $1,446
2024-06-30 $1,311
2024-03-31 $1,168
2023-12-31 $1,021
2023-09-30 $765
2023-06-30 $644
2023-03-31 $529
2022-12-31 $480
2022-09-30 $388
2022-06-30 $287
2022-03-31 $236
2021-12-31 $139
2021-09-30 $-28
2021-06-30 $-99
2021-03-31 $-162
2020-12-31 $-202
2020-09-30 $-557
2020-06-30 $-630
2020-03-31 $-676
2019-12-31 $-696
2019-09-30 $-788
2019-06-30 $-834
2019-03-31 $-824
2018-12-31 $-799
2018-09-30 $-619
2018-06-30 $-666
2018-03-31 $-696
2017-12-31 $-672
2017-09-30 $-662
2017-06-30 $-660
2017-03-31 $-663
2016-12-31 $-621
2016-09-30 $-614
2016-06-30 $-595
2016-03-31 $-575
2015-12-31 $-555
2015-09-30 $-557
2015-06-30 $-514
2015-03-31 $-511
2014-12-31 $-498
2014-09-30 $-499
2014-06-30 $-494
2014-03-31 $-488
2013-12-31 $-475
2013-09-30 $-473
2013-06-30 $-467
2013-03-31 $-457
2012-12-31 $-446
2012-09-30 $-437
2012-06-30 $-420
2012-03-31 $-405
2011-12-31 $-391
2011-09-30 $-379
2011-06-30 $-366
2011-03-31 $-358
2010-12-31 $-346
2010-09-30 $-337
2010-06-30 $-323
2010-03-31 $-311
2009-12-31 $-291
2009-09-30 $-280
2009-06-30 $-266
2009-03-31 $-251
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $33.596B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $188.582B 82.60
Thermo Fisher Scientific (TMO) United States $154.218B 18.65
Edwards Lifesciences (EW) United States $44.793B 29.37
Alcon (ALC) Switzerland $43.149B 29.16
IDEXX Laboratories (IDXX) United States $41.707B 47.93
IQVIA Holdings (IQV) United States $26.668B 14.94
Mettler-Toledo (MTD) United States $24.844B 29.55
STERIS (STE) Ireland $23.875B 26.30
Waters (WAT) United States $20.729B 29.25
SONOVA HOLDING (SONVY) Switzerland $18.648B 0.00
Hologic (HOLX) United States $14.389B 15.63
Sysmex ADR (SSMXY) Japan $10.323B 29.29
Penumbra (PEN) United States $9.933B 77.96
Masimo (MASI) United States $9.319B 34.38
Globus Medical (GMED) United States $8.169B 19.47
Teleflex (TFX) United States $5.447B 8.99
Glaukos (GKOS) United States $5.408B 0.00
TransMedics (TMDX) United States $4.715B 102.50
Integer Holdings (ITGR) United States $4.259B 22.31
PROCEPT BioRobotics (PRCT) United States $3.478B 0.00
LivaNova (LIVN) United Kingdom $2.525B 15.03
Nihon Kohden (NHNKY) Japan $2.253B 25.84
Veracyte (VCYT) United States $2.181B 30.60
Elekta AB (EKTAY) Sweden $2.013B 18.10
Alphatec Holdings (ATEC) United States $1.742B 0.00
Tandem Diabetes Care (TNDM) United States $1.347B 0.00
Artivion (AORT) United States $1.246B 116.76
Pulse Biosciences (PLSE) United States $1.163B 0.00
OPKO Health (OPK) United States $1.094B 0.00
Integra LifeSciences Holdings (IART) United States $1.079B 5.74
Beta Bionics (BBNX) United States $0.842B 0.00
SiBone (SIBN) United States $0.804B 0.00
IRadimed (IRMD) United States $0.773B 39.23
RxSight (RXST) United States $0.622B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.585B 9.09
Mesa Laboratories (MLAB) United States $0.561B 13.15
Delcath Systems (DCTH) United States $0.555B 0.00
OrthoPediatrics (KIDS) United States $0.523B 0.00
AxoGen (AXGN) United States $0.474B 0.00
AngioDynamics (ANGO) United States $0.452B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.433B 0.00
NeuroPace (NPCE) United States $0.424B 0.00
Semler Scientific (SMLR) United States $0.379B 10.09
ClearPoint Neuro (CLPT) United States $0.373B 0.00
Treace Medical Concepts (TMCI) United States $0.371B 0.00
Pacific Biosciences Of California (PACB) United States $0.360B 0.00
908 Devices (MASS) United States $0.250B 0.00
Neuronetics (STIM) United States $0.245B 0.00
Tactile Systems Technology (TCMD) United States $0.238B 14.41
Alpha Tau Medical (DRTS) Israel $0.220B 0.00
Sight Sciences (SGHT) United States $0.210B 0.00
Anteris Technologies Global (AVR) Australia $0.194B 0.00
Inogen (INGN) United States $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.172B 0.00
Biosig Technologies (BSGM) United States $0.172B 0.00
CVRx (CVRX) United States $0.162B 0.00
Rapid Micro Biosystems (RPID) United States $0.155B 0.00
LENSAR (LNSR) United States $0.154B 0.00
Lucid Diagnostics (LUCD) United States $0.141B 0.00
Accuray (ARAY) United States $0.132B 0.00
Atossa Genetics (ATOS) United States $0.118B 0.00
Monogram Orthopaedics (MGRM) United States $0.094B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.082B 50.00
EnVVeno Medical (NVNO) United States $0.078B 0.00
InspireMD (NSPR) United States $0.074B 0.00
EDAP TMS S.A (EDAP) France $0.067B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
Spectral AI (MDAI) United States $0.056B 0.00
Positron (POSC) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
Baird Medical Investment Holdings (BDMD) $0.031B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.36